Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
Clinical trial NCT01845805 · COMPLETED
Trial details
- NCT number
- NCT01845805
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-10
- Primary completion
- 2021-04-09
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.